Skip to main content
Caplight Logo









SYTE.bio

SYTE.bio

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://syte.bio/

Last Round

Accelerator

Mar 15, 2022

Total Funding Raised

$2,500

Company Overview

SYTE.bio is a synthetic biology company that develops precision DNA and RNA-based therapeutic platforms for vaccines and gene therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

synthetic biologynon-viral gene therapysynbiogene therapyRNA therapeuticsDNA vaccinenucleic acid therapeuticsgene deliverybiotech platformminicircle DNAdrug delivery systemscomputational biologybioinformaticsnext-gen vaccinesgenetic engineering

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SYTE.bio Comparables

Compare SYTE.bio with similar companies based on industry and business-model similarity.

SYTE.bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Code Biotherapeutics
88%
Serif Biomedicines
80%
Typewriter Therapeutics
80%

SYTE.bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorMar 15, 2022

Key People

Founding team and executive leadership

Martin Williams

CEO & Founder

Founding Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 3, 2026

    Monthly visitors grew 190% MoM, reaching 2.5K.

  • May 2, 2025

    Monthly visitors grew 122% MoM, reaching 1.6K.

SYTE.bio Filings

Explore SEC and related filing metadata, where available.

SYTE.bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about SYTE.bio's valuation, stock price, and market status.

Is SYTE.bio a public or private company?

SYTE.bio is a private company.

What is the current stock price of SYTE.bio?

SYTE.bio is a private company with no public stock price. Caplight tracks SYTE.bio's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is SYTE.bio worth (valuation)?

Valuation information for SYTE.bio is not publicly available.

Can I buy SYTE.bio stock?

SYTE.bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was SYTE.bio's last funding round?

SYTE.bio's most recent funding round was Accelerator on March 15, 2022.

Who are the main investors in SYTE.bio?

Investor information for SYTE.bio is not publicly disclosed.

Will SYTE.bio IPO soon?

No public IPO plans have been announced for SYTE.bio.

How can I track SYTE.bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SYTE.bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range6
Year Founded2021
Last FundingMar 15, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?